OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance

Core Viewpoint - OrthoPediatrics Corp. has announced preliminary financial results for Q3 2025 and revised its financial guidance for the full year 2025, indicating a decrease in expected revenue due to various operational challenges [1][3][4]. Financial Performance - Preliminary unaudited net revenue for Q3 2025 is approximately $61.2 million, reflecting a 12% increase from $54.6 million in Q3 2024 [8]. - Domestic net revenue for Q3 2025 is expected to be around $48.7 million, representing a 14% growth year-over-year, while international net revenue is projected at $12.5 million, showing a 6% increase [8]. - Excluding 7D capital sales, the preliminary net revenue for Q3 2025 is approximately $60.7 million, a 17% increase from $51.8 million in Q3 2024 [8]. Updated Financial Guidance - For the full year 2025, the company now expects revenue between $233.5 million and $234.5 million, down from the previous guidance of $237.0 million to $242.0 million, which still represents a growth of 14% to 15% over 2024 revenue [3][4]. - The company has reiterated its expectation for annual set deployment at $15.0 million and adjusted EBITDA guidance in the range of $15.0 million to $17.0 million for 2025 [3]. Operational Challenges - The company faced headwinds in late September 2025, primarily due to delayed 7D capital sales and challenges in the Latin and South America segments, which contributed to a revenue shortfall [4]. - The company acknowledges the difficulty in forecasting order timing across these segments and plans to reflect minimal sales growth from these areas for Q4 and beyond [4]. Company Overview - OrthoPediatrics focuses exclusively on pediatric orthopedics and has developed a comprehensive product offering to improve the lives of children with orthopedic conditions [12]. - The company markets over 80 products across three major categories: trauma and deformity, scoliosis, and sports medicine/other procedures, distributing its products in the U.S. and over 70 countries [12].